Having said all these things, I also acknowledge that, despite being in an extremely competitive and difficult pharmaceutical market, there are still many very good examples of marketing to celebrate.

For example, a pharma company launching a new migraine ... the pharma industry faces strict FDA guidelines for social media marketing. Brands must ensure transparency, accuracy, and compliance ...

Take, for example, the rules governed by the U.S ... The saga of Purdue Pharma's marketing of OxyContin stands as a stark reminder of this. Accused of aggressive promotion strategies, Purdue ...

For example, marketers would know not to drop ... This improves customer loyalty and retention. In pharmaceutical marketing, a well-managed omnichannel strategy can improve the prescribing ...

From our perspective of helping pharmaceutical marketers in HCP marketing, we see AI becoming more a part of the transactional aspects of what pharmaceutical marketers do. For example, segmentation.

In a column for Econsultancy earlier this month, Littleton pointed out some good examples of pharma companies using social media. She highlighted GlaxoSmithKline’s Twitter account, which focuses ...

Where do we go from here? Like other emerging social channels, LinkedIn will gain momentum and acceptance within pharma marketing as new examples and use cases continue to emerge. The platform has the ...

Hey, AbbVie, what do you say? The Cubs are gonna strike out cancer today. | A new partnership between the Chicago-based ...

The Trends That Will Shape Pharma Marketing In 2025. Tenuta emphasizes the importance of embracing AI as an innovation and highlights specific examples of how AI is being used to improve efficiency ...

The example above illustrates the power of ... can be marketed and what claims can be made. The future of pharmaceutical marketing is unequivocally multicultural. As markets continue to diversify ...

Pharmaceutical market research analysis (PMRA) can validate a product's potential reach and market penetration capabilities. Investors use it to put a value on drug-making companies and their ...